PET imaging of noradrenaline transporters in Parkinson's disease: focus on scan time.


Journal

Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 01 10 2018
accepted: 01 10 2018
pubmed: 8 10 2018
medline: 21 5 2019
entrez: 8 10 2018
Statut: ppublish

Résumé

In subjects with idiopathic Parkinson's disease (PD) the functional state of the locus coeruleus and the subtle derangements in the finely tuned dopamine-noradrenaline interplay are largely unknown. The PET ligand (S,S)-[ Ten patients with idiopathic PD underwent dynamic C-11 MRB PET (120 min duration) and brain magnetic resonance imaging. Model-based (i.e., simplified and multilinear reference tissue model 2) non-displaceable binding potentials (BP) of selected brain regions were analyzed for a 90 min scan protocol and compared with BP derived from static 30-min data with different starting times (30, 40, 50 and 60 min) after C-11 MRB injection. Intraclass correlation coefficient and linear regression analysis were used to explore the association between BP of different scan durations. Spearman's ρ served to describe the correlation of BP with demographic and clinical parameters. With respect to kinetic models, BP An acquisition time of 30 min, starting 50 or 60 min after C-11 MRB injection, allows a reliable estimation of noradrenaline transporter binding values in Parkinsonian people. A short acquisition time can significantly reduce the discomfort of Parkinsonian patients and facilitate PET studies, especially in the medication-off-state.

Identifiants

pubmed: 30293197
doi: 10.1007/s12149-018-1305-5
pii: 10.1007/s12149-018-1305-5
pmc: PMC6373329
doi:

Substances chimiques

Norepinephrine Plasma Membrane Transport Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-77

Références

Mov Disord. 2000 Jul;15(4):692-8
pubmed: 10928580
Mov Disord. 2002 Jul;17(4):782-8
pubmed: 12210876
J Cereb Blood Flow Metab. 2002 Dec;22(12):1440-52
pubmed: 12468889
Hum Brain Mapp. 2003 Aug;19(4):224-47
pubmed: 12874777
J Cereb Blood Flow Metab. 2003 Sep;23(9):1096-112
pubmed: 12973026
Nature. 1957 Nov 30;180(4596):1200
pubmed: 13483658
Synapse. 2003 Dec 15;50(4):345-52
pubmed: 14556239
Chirality. 2004 Aug;16(7):475-81
pubmed: 15236345
Brain. 2005 Jun;128(Pt 6):1314-22
pubmed: 15716302
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494
J Neurochem. 2005 Jul;94(2):337-51
pubmed: 15998285
Brain Res. 1990 Jul 16;523(1):134-8
pubmed: 1698514
Biochem Pharmacol. 2007 Jul 15;74(2):177-90
pubmed: 17416354
Nucl Med Biol. 2007 Aug;34(6):667-79
pubmed: 17707807
Neuroreport. 2007 Sep 17;18(14):1499-502
pubmed: 17712282
Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):424-38
pubmed: 17968545
Exp Neurol. 2008 Jul;212(1):226-9
pubmed: 18501351
Brain. 1991 Oct;114 ( Pt 5):2283-301
pubmed: 1933245
Neuroimage. 2009 Oct 1;47(4):1261-7
pubmed: 19524044
Synapse. 2010 Jan;64(1):30-8
pubmed: 19728366
Biol Psychiatry. 2010 Nov 1;68(9):854-60
pubmed: 20691429
Neuroimage. 2011 May 1;56(1):268-79
pubmed: 20869448
Ann Neurol. 2011 May;69(5):803-10
pubmed: 21246604
BMC Neurol. 2011 Jul 21;11:88
pubmed: 21777421
Front Hum Neurosci. 2012 Jan 03;5:179
pubmed: 22287946
JAMA Psychiatry. 2013 Nov;70(11):1199-205
pubmed: 24048210
Mov Disord. 2014 Dec;29(14):1710-9
pubmed: 25297066
Front Neurol. 2014 Dec 15;5:242
pubmed: 25566170
Nucl Med Biol. 2016 May;43(5):318-23
pubmed: 27150035
J Nucl Med. 2017 Jul;58(7):1140-1145
pubmed: 27980046
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1056-1064
pubmed: 28066877
J Nucl Med. 2018 Apr;59(4):659-664
pubmed: 28848039
Ann Clin Transl Neurol. 2017 Aug 11;4(9):632-639
pubmed: 28904985
Brain. 2018 Feb 1;141(2):496-504
pubmed: 29272343
N Engl J Med. 1968 Mar 14;278(11):630
pubmed: 5637779
IEEE Trans Med Imaging. 1998 Jun;17(3):463-8
pubmed: 9735909

Auteurs

Joachim Brumberg (J)

Department of Nuclear Medicine, University Hospital and Julius-Maximilians-University, Oberdürrbacher Straße 6, 97080, Würzburg, Germany.

Johannes Tran-Gia (J)

Department of Nuclear Medicine, University Hospital and Julius-Maximilians-University, Oberdürrbacher Straße 6, 97080, Würzburg, Germany.

Constantin Lapa (C)

Department of Nuclear Medicine, University Hospital and Julius-Maximilians-University, Oberdürrbacher Straße 6, 97080, Würzburg, Germany.

Ioannis U Isaias (IU)

Department of Neurology, University Hospital and Julius-Maximilians-University, Josef-Schneider-Straße 11, 97080, Würzburg, Germany. Isaias_I@ukw.de.

Samuel Samnick (S)

Department of Nuclear Medicine, University Hospital and Julius-Maximilians-University, Oberdürrbacher Straße 6, 97080, Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH